Effect of Resistance Exercise on Energy Balance and Appetite Regulation in Males and Females

February 25, 2026 updated by: National Taiwan Normal University

There is growing evidence that males and females may exhibit different acute responses and long-term adaptations to exercise training. Accordingly, contemporary exercise physiology research increasingly recognizes sex as an important biological variable that may influence appetite regulation and energy balance.

This year's project aims to investigate: (1) appetite regulation and energy balance following acute resistance exercise, and (2) potential sex-based differences in appetite regulation and energy balance in response to resistance exercise.

Understanding both the overall effects of resistance exercise and sex-related variability in these responses is important for improving the physiological interpretation of exercise-induced changes in appetite and energy balance. Such knowledge may help to reduce heterogeneity in exercise research findings and support the development of more precise, evidence-based exercise prescriptions that are applicable to both males and females.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 106
        • Recruiting
        • National Taiwan Normal University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy males and females aged 20-30 years
  • Females with a regular menstrual cycle
  • Stable body weight, defined as no significant change in body weight during the past 6 months
  • Willingness to participate and provide written informed consent

Exclusion Criteria:

  • Obesity, defined as:
  • Body mass index (BMI) > 30 kg/m²
  • Body fat percentage > 25% in males
  • Body fat percentage > 30% in females
  • Hypertension, defined as resting blood pressure > 140/90 mmHg
  • History of cardiovascular disease
  • History of cancer
  • History of liver disease
  • History of kidney disease
  • Presence of any medical condition that may interfere with study outcomes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: males
Resistance exercises are in the following order: squat, bench press, deadlift. Each exercise consists of 3 sets with 7 repetitions, using a load of 70% 1RM with 120 sec of rest between sets.
Resistance exercises are in the following order: squat, bench press, deadlift. Each exercise consists of 3 sets with 7 repetitions, using a load of 70% 1RM with 120 sec of rest between sets.
No Intervention: males control
Participants remained seated at rest during the control trial.
Experimental: females exercise
During the early follicular phase, participants performed resistance exercises in the following order: squat, bench press, and deadlift. Each exercise consisted of three sets of seven repetitions performed at 70% of one-repetition maximum (1RM), with 120 s of rest between sets.
During the early follicular phase, participants completed a standardized resistance exercise protocol consisting of squat, bench press, and deadlift, performed in a fixed order. Each exercise comprised three sets of seven repetitions at 70% of one-repetition maximum (1RM), with 120 s of rest between sets.
No Intervention: females control
During the early follicular phase, participants remained seated at rest during the control trial.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in acyl-Ghrelin
Time Frame: 3 hours during each study intervention
acyl-Ghrelin in pg/mL
3 hours during each study intervention
Change in PYY
Time Frame: 3 hours during each study intervention
PYY in pg/mL
3 hours during each study intervention
Change in lactate
Time Frame: 3 hours during each study intervention
lactate in mmol/L
3 hours during each study intervention
change in Cortisol
Time Frame: 3 hours during each study intervention
Cortisol mcg/dL
3 hours during each study intervention
Subjective appetite
Time Frame: 3 hours during each study intervention
The appetite perceptions are obtained through a 0-100 mm visual analog scale. The variables assessed include perceptions of hunger (i.e., "How hungry do you feel?"), satisfaction (i.e., "How satisfied do you feel?"), fullness (i.e., "How full do you feel?"), prospective food consumption (i.e., "How much do you think you can eat?"), and nausea (i.e., "How nauseous do you feel?"), with 0 indicating "not at all" and 100 signifying "extremely.".
3 hours during each study intervention
Energy intake
Time Frame: The Before day, the durning day, and the day following the experiment.
Participants will be required to record their diet for the day before, the current day (include following exercise ad-libitum), and the day following the experiment. The energy intake include absolute energy intake and relative energy intake .
The Before day, the durning day, and the day following the experiment.
Energy expenditure
Time Frame: The Before day, the durning day, and the day following the experiment.
Energy expenditure will include resting energy expenditure (REE), exercise energy expenditure, and non-exercise energy expenditure. REE will be measured using indirect calorimetry (MetaLyzer 3B; VO₂ and VCO₂ exchange). Exercise energy expenditure will be recorded during the resistance exercise session, and non-exercise energy expenditure will be assessed using an accelerometer. Total energy expenditure will be calculated as the sum of these components.
The Before day, the durning day, and the day following the experiment.
Energy Balance
Time Frame: The Before day, the durning day, and the day following the experiment.

Energy balance will be calculated as total energy intake (EI) minus total energy expenditure (TEE).

Total energy intake will include energy consumed during the laboratory ad-libitum meal and energy intake recorded outside the laboratory during the monitoring period.

Total energy expenditure will include resting energy expenditure, exercise energy expenditure, and non-exercise energy expenditure, as previously described.

Energy balance will be expressed in kilocalories (kcal), with positive values indicating energy surplus and negative values indicating energy deficit.

The Before day, the durning day, and the day following the experiment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leeds food preference questionnaire
Time Frame: 3 hours during each study intervention

Explicit liking A visual analog scale ranging from 0 to 100 mm is utilized to evaluate the question, "How pleasant would it be to taste some of this food now?" with 0 indicating "not at all" and 100 signifying "extremely."

Explicit wanting A visual analog scale ranging from 0 to 100 mm is utilized to evaluate the question, "How much do you want some of this food now?" with 0 indicating "not at all" and 100 signifying "extremely."

Implicit wanting Participants are given a set of food image pairs and are asked to select their preference by answering the question, "Which food do you desire the most at the moment?". The implicit wanting calculation involves further consideration of response time data based on preference choices using a standardized equation.

Relative preference Participants are given a set of food image pairs and are asked to select their preference by answering the question, "Which food do you desire the most at the moment?".

3 hours during each study intervention
Leeds food preference questionnaire
Time Frame: 3 hours during each study intervention

Taste appeal bias Taste preference (savoury or sweet) is calculated by subtracting the mean savory scores from the mean sweet scores. Positive values suggest a preference for sweet foods, while negative scores indicate a preference for savory foods, and a score of 0 signifies an equal preference between taste categories.

Fat appeal bias Fat preference (high or low) is calculated by subtracting the mean low-fat scores from the mean high-fat scores. Positive values suggest a preference for high-fat foods, while negative scores indicate a preference for low-fat or savory foods, and a score of 0 signifies an equal preference between fat content.

3 hours during each study intervention
10 Ratings of Perceived Exertion (RPE)
Time Frame: 1-hour during each exercise intervention

Ratings of Perceived Exertion (RPE) will be assessed using the Borg Category-Ratio 10 (CR10) scale during resistance exercise.

The scale ranges from 1 to 10, where 1 indicates very light exertion and 10 indicates maximal exertion. Higher scores represent greater perceived exercise intensity.

1-hour during each exercise intervention
Heart rate (HR)
Time Frame: 3-hour during each study intervention
HR will be measured during each study intervention. HRV (Heart Rate Variability) will be measured during each study intervention.
3-hour during each study intervention
Estradiol (E2)
Time Frame: Baseline for each trial (female participants only).
Estradiol (E2) concentration in pg/mL, measured from blood samples. Baseline measurements will be used to confirm menstrual cycle phase for each trial.
Baseline for each trial (female participants only).
Progesterone (P4)
Time Frame: Baseline for each trial (female participants only).
Progesterone (P4) concentration in ng/mL (or nmol/L), measured from blood samples. Baseline hormone levels will be assessed at each trial.
Baseline for each trial (female participants only).
Concentric Peak Velocity
Time Frame: During each exercise condition.
Concentric peak velocity (m/s) will be measured using the Gymaware system during resistance exercise.
During each exercise condition.
Concentric Mean Velocity
Time Frame: During each exercise condition
Concentric mean velocity (m/s) will be measured using the Gymaware system during resistance exercise.
During each exercise condition
Eccentric Peak Velocity
Time Frame: During each exercise condition
Eccentric peak velocity (m/s) will be measured using the Gymaware system during resistance exercise.
During each exercise condition
Concentric Mean Power
Time Frame: During each exercise condition
Concentric mean power (W) will be measured using the Gymaware system during resistance exercise.
During each exercise condition
Relative Concentric Mean Power
Time Frame: During each exercise condition
Mean concentric power normalized to body mass (W/kg) will be measured using the Gymaware system during resistance exercise.
During each exercise condition
Concentric Work
Time Frame: During each exercise condition
Concentric work (J) will be measured using the Gymaware system during resistance exercise.
During each exercise condition
Velocity Loss
Time Frame: During each exercise condition
Velocity loss (%) across sets during resistance exercise will be calculated using data obtained from the Gymaware system.
During each exercise condition

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

January 7, 2026

First Submitted That Met QC Criteria

February 25, 2026

First Posted (Actual)

March 2, 2026

Study Record Updates

Last Update Posted (Actual)

March 2, 2026

Last Update Submitted That Met QC Criteria

February 25, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 202412HM018

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resistance Exercise

Clinical Trials on resistance exercise (males)

Subscribe